Dr. Mali's Top 5 Predictions in Ophthalmology for 2022

ByJoshua Mali, MD

In this episode I share my top 5 predictions in ophthalmology for 2022, including my thoughts on the future of COVID-19 and ocular gene therapy.

Welcome to another exciting episode of Eye Care insider :50
My top 5 predictions for 2022 1:16
Prediction #1 – on COVID-19 1:27
Prediction #2 – on wet AMD 2:43
Prediction #3 – on ocular gene therapy 4:05
Prediction #4 – on geographic atrophy 5:05
Prediction #5 – on ophthalmology media platforms 7:23
Thanks for listening 9:20

We’d love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN.

Published by:

Sources/Disclosures

Collapse

Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; grant/research support from Alimera Sciences, Allergan/AbbVie, Chengdu Kanghong Biotechnology, Genentech, Notal Vision, Regeneron and Santen; consulting for Alimera Sciences, Allergan/AbbVie, Eyepoint Pharmaceuticals, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis, Regeneron and Sun Pharmaceuticals; speaker bureau for Alimera Sciences, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis and Sun Pharmaceuticals; and stock/shareholder with AbbVie and Regeneron.

Read more

Dr. Mali's Top 5 Predictions in Ophthalmology for 2022

Eye Care Insider

Related Content